Bladder Cancer

News

Experts Rule Out Urinary Calprotectin as Tumor Marker for Bladder Cancer

12/12/2019

According to findings from a cross-sectional study, urinary calprotectin cannot be used as a specific tumor marker for bladder cancer.

According to findings from a...

12/12/2019

Oncology

News

Increased Use of Perioperative and Neoadjuvant Chemo in Bladder Cancer

12/10/2019

Use of perioperative and neoadjuvant chemo in patients with bladder cancer has risen in Quebec, but these rates are still lower than those reported in most developed countries.

Use of perioperative and...

12/10/2019

Oncology

News

Experts Show That YAP1/mTOR Interaction Accelerates Bladder Cancer Progression

12/05/2019

Study results suggest that the interaction between YAP1 and mTOR hastens disease progression in patients with bladder cancer.

Study results suggest that the...

12/05/2019

Oncology

Education and Rehab Program Improves QoL in Patients With Muscle Invasive Bladder Cancer

11/08/2019

A patient education and rehab program relieves anxiety and depression in patients with muscle invasive bladder cancer receiving chemo.

A patient education and rehab...

11/08/2019

Oncology

Avelumab Shows Promise in MMRD Endometrial Cancer, Regardless of PD-L1 Status

09/26/2019

Investigators demonstrated the promising activity of avelumab in a study of patients with MMRD endometrial cancer.

Investigators demonstrated the...

09/26/2019

Oncology

Combo Therapy Promising for Cisplatin-Ineligible Metastatic Urothelial Cancer

08/23/2019

Findings from a recent trial show gemcitabine–eribulin as favorable combo for cisplatin-ineligible patients with metastatic urothelial cancer.

Findings from a recent trial...

08/23/2019

Oncology

News

Avelumab Safe and Effective for Metastatic Urothelial Cancer

02/19/2019

Avelumab therapy in patients with metastatic urothelial cancer yielded manageable safety and durable clinical activity, according to a recent study.

Avelumab therapy in patients...

02/19/2019

Oncology

Adding Chemo Postsurgery Improves Survival in Locally Advanced Bladder Cancer

02/14/2019

Study results presented at the 2019 ASCO GI Cancers Symposium support the use of adjuvant therapies to address local and distant disease in patients with locally advanced bladder cancer.

Study results presented at the...

02/14/2019

Oncology

Low MSH2 Expression Tied to Cisplatin Resistance in Bladder Cancer

12/21/2018

Low expression of MSH2, a component of the mismatch-repair pathway, is associated with resistance to cisplatin treatment in bladder cancer, researchers report.

Low expression of MSH2, a...

12/21/2018

Oncology

10/02/2018

Patients with high- and low-risk bladder cancer undergo surveillance at comparable rates, despite recommendations calling for twice this frequency in high-risk patients.

Patients with high- and low-risk...

10/02/2018

Oncology